Further evidence that FSH causes bone loss independently of low estrogen

Endocrine

Volumn 41, Issue 2, 2012, Pages 171-175

  Iqbal, Jameel ^a   Blair, Harry C ^b   Zallone, Alberta ^c   Sun, Li ^a   Zaidi, Mone ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; FOLLITROPIN; FOLLITROPIN RECEPTOR; THYROTROPIN;

AMENORRHEA; BONE DENSITY; BONE MASS; BONE REMODELING; BONE TURNOVER; CLIMACTERIUM; ESTROGEN THERAPY; FOLLITROPIN BLOOD LEVEL; HORMONE SUBSTITUTION; HUMAN; HYPERTHYROIDISM; HYPOGONADISM; MENOPAUSE; NONHUMAN; OSTEOLYSIS; OSTEOPOROSIS; PRIORITY JOURNAL; REVIEW;

EID: 84862648664     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-012-9626-y     Document Type: Review

References (38)

1. E.C. Reifenstein Jr., F. Albright, The metabolic effects of steroid hormones in osteoporosis. J. Clin. Invest. 26, 24-56 (1947)
2. J. Iqbal, M. Zaidi, Understanding estrogen action during menopause. Endocrinology 150, 3443-3445 (2009)
3. M.R. Sowers, H. Zheng, M.L. Jannausch, D. McConnell, B. Nan, S. Harlow, J.F. Randolph Jr., Amount of bone loss in relation to time around the final menstrual period and follicle-stimulating hormone staging of the transmenopause. J. Clin. Endocrinol. Metabol. 95, 2155-2162 (2010)
4. M.R. Sowers, H. Zheng, D. McConnell, B. Nan, S. Harlow, J.F. Randolph Jr, Follicle-stimulating hormone and its rate of change in defining menopausal transition changes. J. Clin. Endocrinol. Metabol. 93, 3958-3964 (2008)
5. M.R. Sowers, M. Jannausch, D. McConnell, R. Little, G.A. Greendale, J.S. Finkelstein, R.M. Neer, J. Johnston, B. Ettinger, Hormone predictors of bone mineral density changes during the menopausal transition. J. Clin. Endocrinol. Metab. 91, 1261-1267 (2006)
6. J.F. Randolph Jr, M. Sowers, I.V. Bondarenko, S.D. Harlow, J.L. Luborsky, R.J. Little, Change in estradiol and follicle-stimulating hormone across the early menopausal transition: effects of ethnicity and age. J. Clin. Endocrinol. Metab. 89, 1555-1561 (2004) (Pubitemid 38507902)
7. G. Rannevik, S. Jeppsson, O. Johnell, B. Bjerre, Y. Laurell- Borulf, L. Svanberg, A longitudinal study of the peri-menopausal transition: altered profiles of steroid and pituitary hormones. SHBG and bone mineral density. Maturitas 61, 67-77 (2008)
8. E. Abe, R.C. Marians, W. Yu, X.B. Wu, T. Ando, Y. Li, J. Iqbal, L. Eldeiry, G. Rajendren, H.C. Blair, T.F. Davies, M. Zaidi, TSH is a negative regulator of skeletal remodeling. Cell 115, 151-162 (2003) (Pubitemid 37329579)
9. L. Sun, Y. Peng, A.C. Sharrow, J. Iqbal, Z. Zhang, D.J. Papachristou, S. Zaidi, L.L. Zhu, B.B. Yaroslavskiy, H. Zhou, A. Zallone, M.R. Sairam, T.R. Kumar, W.Bo, J. Braun, L. Cardoso- Landa, M.B. Schaffler, B.S. Moonga, H.C. Blair, M. Zaidi, FSH directly regulates bone mass. Cell 125, 247-260 (2006)
10. M. Zaidi, Skeletal remodeling in health and disease. Nature Med. 13, 791-801 (2007) (Pubitemid 47038187)
11. B. Devleta, B. Adem, S. Senada, Hypergonadotropic amenorrhea and bone density: new approach to an old problem. J. Bone Miner. Metab. 22, 360-364 (2004) (Pubitemid 38980953)
12. A. Podfigurna-Stopa, P. Pludowski, M. Jarowski, R. Lorenc, A.R. Genazzani, B. Meczekalski, Skeletal status and body composition in young women with functional hypothalamic amenhorrea. Gynaecol. Endocrinol. (2011, Epub ahead of print)
13. D. Rendina, F. Gianfrancesco, G. De Filippo, D. Merlotti, T. Esposito, A. Mingione, R. Nuti, P. Strazzullo, G. Mossetti, L. Gennari, FSHR gene polymorphisms influence bone mineral density and bone turnover in post-menopausal women. Eur. J. Endocrinol. 163, 165-172 (2010)
14. S. Liu, Y. Cheng, M. Fan, D. Chen, Z. Bian, FSH aggravates periodontitis-related bone loss in ovariectomized rats. J. Dent. Res. 89, 366-371 (2010)
15. S. Liu, Y. Cheng, W. Xu, Z. Bian, Protective effects of folliclestimulating hormone inhibitor on alveolar bone loss resulting from experimental periapical lesions in ovariectomized rats. J. Endod. 36, 658-663 (2010)
16. M.R. Sowers, G.A. Greendale, I. Bondarenko, J.S. Finkelstein, J.A. Cauley, R.M. Neer, B. Ettinger, Endogenous hormones and bone turnover markers in pre- and perimenopausal women: SWAN. Osteoporos. Int. 14, 191-197 (2003) (Pubitemid 40826231)
17. Z.R. Xu, A.H. Wang, X.P. Wu, H. Zhang, Z.F. Sheng, X.Y. Wu, H. Xie, X.H. Luo, E.Y. Liao, Relationship of age-related concentrations of serum FSH and LH with bone mineral density, prevalence of osteoporosis in native Chinese women. Clin. Chim. Acta 400, 8-13 (2009)
18. X.Y. Wu, X.P. Wu, H. Xie, H. Zhang, Y.Q. Peng, L.Q. Yuan, X. Su, X.H. Luo, E.Y. Liao, Age-related changes in biochemical markers of bone turnover and gonadotropin levels and their relationship among Chinese adult women. Osteoporos. Int. 21, 275-285 (2009)
19. E. Cheung, S. Tsang, C. Bow, S. Yueng, C. Loomg, C.L. Cheung, A. Kan, S. Lo, S. Tam, G. Tang, A. Kung, Bone loss during menopausal transition in Chinese women. Maturitas 69, 50-56 (2011)
20. C.M. Gallagher, B.S. Moonga, J.S. Kovach, Cadmium, folliclestimulating hormone, and effects on bone in women age 42-60 years: NHANES III. Environ. Res. 110, 105-111 (2010)
21. A. Garcia-Martin, R. Reyes-Garcia, J.M. Garcia-Castro, P. Rozas- Moreno, F. Escobar-Jimenez, M. Munoz-Torres, Role of serum FSH measurement on bone resorption in postmenopausal women. Endocrine (2011, Epub ahead of print)
22. S. Adami, G. Bianchi, M.L. Brandi, S. Giannini, S. Ortolani, O. DiMunno, B. Frediani, M. Rossini, BONTURNO study group, determinants of bone turnover markers in healthy premenopausal women. Calcif. Tiss. Int. 82, 341-347 (2008)
23. M. Zaidi, C.H. Turner, E. Canalis, R. Pacifici, L. Sun, J. Iqbal, X.E. Guo, S. Silverman, S. Epstein, C.J. Rosen, Bone loss or lost bone: rationale and recommendations for the diagnosis and treatment of early postmenopausal bone loss. Curr. Osteoporos. Rep. 7, 118-126 (2009)
24. M.L. Gourlay, J.S. Preissner, C.A. Hammet-Stabler, J.B. Renner, J. Rubin, Follicle stimulating hormone and bioavailable estradiol are less important than weight and race in determining bone density in younger post-menopausal women. Osteoporos. Int. 22, 2699-2708 (2011)
25. M.L. Gourlay, B.L.Specker, C. Li, C.A. Hammett-Stabler, J.B. Renner, J.E. Rubin, Follicle-stimulating hormone is independently associated with lean mass but not BMD in younger postmenopausal women. Bone 50, 311-316 (2012)
26. L.J. Robinson, I. Tourkova, Y. Wang, A.C. Sharrow, M.S. Landau, B.B. Yaroslavskiy, L. Sun, M. Zaidi, H.C. Blair, FSH receptor isoforms and FSH-dependent gene transcription in human monocytes and osteocytes. Biochem. Biophys. Res. Commun. 394, 12-17 (2010)
27. L. Sun, Z. Zhang, L.L. Zhu, Y. Peng, X. Liu, J. Li, M. Agrawal, L.J. Robinson, J. Iqbal, H.C. Blair, M. Zaidi, Further evidence for a direct pro-resorptive actions of FSH. Biochem. Biophys. Res. Commun. 394, 6-11 (2010)
28. Y. Wu, J. Torchia, W. Yao, N.E. Lane, L.L. Lanier, M.C. Nakamura, M.B. Humphrey, Bone microenvironment specific roles of ITAM adapter signaling during bone remodeling induced by acute estrogen-deficiency. PLoS. One. 2, e586 (2007)
29. J.G. Cannon, B. Kraj, G. Sloan, Follicle-stimulating hormone promotes RANK expression on human monocytes. Cytokine 53, 141-144 (2011)
30. J. Iqbal, L. Sun, T.R. Kumar, H.C. Blair, M. Zaidi, Folliclestimulating hormone stimulates TNF production from immune cells to enhance osteoblast and osteoclast formation. Proc. Natl. Acad. Sci. USA 103, 14925-14930 (2006) (Pubitemid 44527830)
31. J.G. Cannon, M. Cortez-Cooper, E. Meaders, J. Stallings, S. Haddow, B. Kraj, G. Sloan, A. Mulloy, Follicle-stimulating hormone, interleukin-1, and bone density in adult women. Am. J. Physiol. Regul. Integr. Comp. Physiol. 298, R790-R798 (2010)
32. E.R. Gertz, N.E. Silverman, K.S. Wise, K.B. Hanson, D.L. Alekel, J.W. Stewart, C.D. Perry, S.N. Bhupathiraju, M.L. Kohut, M.D. Van Loan, Contribution of serum inflammatory markers to changes in bone mineral content and density in postmenopausal women: a 1-year investigation. J. Clin. Densitom. 13, 277-282 (2010)
33. C.M. Allan, R. Kalak, C.R. Dunstan, K.J. McTavish, H. Zhou, D.J. Handlesman, M.J. Seibel, Follicle-stimulating hormone increases bone mass in female mice. Proc. Natl. Acad. Sci. USA. 107, 22629-22634 (2010)
34. V. Ritter, B. Thuering, P. Saint Mezard, N.H. Luong-Nguyen, Y. Seltenmeyer, U. Junker, B. Fournier, M. Susa, F. Morvan, Follicle stimulating hormone does not impact male bone mass in vivo or human male osteoclasts in vitro. Calcif. Tiss. Int. 82, 383-391 (2008)
35. H. Kawai, M. Furuhashi, N. Suganuma, Serum follicle stimulating hormone level is a predictor of bone mineral density in patients with hormone replacement therapy. Arch. Gynecol. Obstet. 269, 192-195 (2004) (Pubitemid 38374707)
36. M.T. Drake, L.K. McCready, K.A. Hoey, E.J. Atkinson, S. Khosla, Effects of suppression of follicle-stimulating hormone secretion on bone resorption markers in post-menopausal women. J. Clin. Endocrinol. Metabol. 95, 5063-5068 (2010)
37. K.M. Nicks, T.W. Fowler, D. Gaddy, Reproductive hormones and bone. Curr. Osteoporos. Rep. 8, 60-67 (2010)
38. M. Zaidi, Neural surveillance of skeletal homeostasis. Cell. Metabol. 1, 219-221 (2005) (Pubitemid 43960612)